NOD2 polymorphisms associated with cancer risk: A meta-analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Liu, Jingwei ^a   He, Caiyun ^a   Xu, Qian ^a   Xing, Chengzhong ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; NOD2 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LARYNX CANCER; LUNG CANCER; MARGINAL ZONE LYMPHOMA; MELANOMA; NOD2 GENE; NONHODGKIN LYMPHOMA; NUCLEIC ACID BASE SUBSTITUTION; OUTCOMES RESEARCH; PANCREAS CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; UROGENITAL TRACT CANCER; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; PROGNOSIS; RISK ASSESSMENT;

EID: 84895886844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089340     Document Type: Article

References (48)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM (2010) The global burden of cancer: priorities for prevention. Carcinogenesis 31: 100-110.
3. Zaridze DG (2008) Molecular epidemiology of cancer. Biochemistry (Mosc) 73: 532-542.
4. Deng W, Xie J (2012) NOD2 signaling and role in pathogenic mycobacterium recognition, infection and immunity. Cell Physiol Biochem 30: 953-963.
5. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872. (Pubitemid 36800360)
6. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603. (Pubitemid 32531408)
7. Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, et al. (2005) Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11: 681-685. (Pubitemid 40220757)
8. Kurzawski G, Suchy J, Kladny J, Grabowska E, Mierzejewski M, et al. (2004) The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 64: 1604-1606. (Pubitemid 38428679)
9. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. (Pubitemid 34746062)
10. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
12. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
13. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629-634. (Pubitemid 27387172)
14. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, et al. (2010) Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer 10: 382.
15. Nej K, Bartsch DK, Sina-Frey M, Rieder H, Hahn SA, et al. (2004) The NOD2 3020insC Mutation and The Risk of Familial Pancreatic Cancer? Hered Cancer Clin Pract 2: 149-150.
16. Ture-Ozdemir F, Gazouli M, Tzivras M, Panagos C, Bovaretos N, et al. (2008) Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res 28: 3697-3700.
17. Rosenstiel P, Hellmig S, Hampe J, Ott S, Till A, et al. (2006) Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 8: 1188-1198. (Pubitemid 43871652)
18. Angeletti S, Galluzzo S, Santini D, Ruzzo A, Vincenzi B, et al. (2009) NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol 70: 729-732.
19. Rigoli L, Di Bella C, Fedele F, Procopio V, Amorini M, et al. (2010) TLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesis. Anticancer Res 30: 513-517.
20. Wex T, Ebert MP, Kropf S, Dierkes J, Schuttler K, et al. (2008) Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany. Anticancer Res 28: 757-762. (Pubitemid 351578918)
21. Hnatyszyn A, Szalata M, Stanczyk J, Cichy W, Slomski R (2010) Association of c.802C>T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients. Exp Mol Pathol 88: 388-393.
22. Jaworowska E, Masojc B, Tarnowska C, Brzosko M, Flicinski J, et al. (2006) Association between early-onset breast and laryngeal cancers. Breast Cancer Res Treat 97: 215-219.
23. Irmejs A, Miklasevics E, Boroschenko V, Gardovskis A, Vanags A, et al. (2006) Pilot study on low penetrance breast and colorectal cancer predisposition markers in latvia. Hered Cancer Clin Pract 4: 48-51.
24. Lener MR, Oszutowska D, Castaneda J, Kurzawski G, Suchy J, et al. (2006) Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat 95: 141-145.
25. Huzarski T, Lener M, Domagala W, Gronwald J, Byrski T, et al. (2005) The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 89: 91-93. (Pubitemid 40228452)
26. Magnowski P, Medrek K, Magnowska M, Stawicka M, Kedzia H, et al. (2008) The 3020insC NOD2 gene mutation in patients with ovarian cancer. Ginekol Pol 79: 544-549.
27. Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, et al. (2005) NOD2 variants and the risk of malignant melanoma. Eur J Cancer Prev 14: 143-146. (Pubitemid 40516976)
28. Lubinski J, Huzarski T, Kurzawski G, Suchy J, Masojc B, et al. (2005) The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract 3: 59-63. (Pubitemid 40978998)
29. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjose S, et al. (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171: 267-276.
30. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, et al. (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7: 27-38. (Pubitemid 43025390)
31. Forrest MS, Skibola CF, Lightfoot TJ, Bracci PM, Willett EV, et al. (2006) Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol 134: 180-183. (Pubitemid 43893909)
32. Papaconstantinou I, Theodoropoulos G, Gazouli M, Panoussopoulos D, Mantzaris GJ, et al. (2005) Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer 114: 433-435. (Pubitemid 40279965)
33. Mockelmann N, von SchonfelsW, Buch S, von Kampen O, Sipos B, et al. (2009) Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC Gastroenterol 9: 79.
34. Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, et al. (2007) Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer 7: 54.
35. Freire P, Portela F, Donato MM, Figueiredo P, Ferreira M, et al. (2010) CARD15 mutations and colorectal cancer in a South European country. Int J Colorectal Dis 25: 1211-1219.
36. Roberts RL, Gearry RB, Allington MD, Morrin HR, Robinson BA, et al. (2006) Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res 66: 2532-2535.
37. Tuupanen S, Alhopuro P, Mecklin JP, Jarvinen H, Aaltonen LA (2007) No evidence for association of NOD2 R702W and G908R with colorectal cancer. Int J Cancer 121: 76-79. (Pubitemid 46753853)
38. Szeliga J, Sondka Z, Jackowski M, Jarkiewicz-Tretyn J, Tretyn A, et al. (2008) NOD2/CARD15 polymorphism in patients with rectal cancer. Med Sci Monit 14: CR480-484.
39. Suchy J, Klujszo-Grabowska E, Kladny J, Cybulski C, Wokolorczyk D, et al. (2008) Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 8: 112.
40. Vogel U, Christensen J, Dybdahl M, Friis S, Hansen RD, et al. (2007) Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 624: 88-100. (Pubitemid 47588301)
41. Alhopuro P, Ahvenainen T, Mecklin JP, Juhola M, Jarvinen HJ, et al. (2004) NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res 64: 7245-7247. (Pubitemid 39372060)
42. Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, et al. (2008) Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol 26: 98-103. (Pubitemid 351951338)
43. Kersse K, Bertrand MJ, Lamkanfi M, Vandenabeele P (2011) NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev 22: 257-276.
44. Strober W, Watanabe T (2011) NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol 4: 484-495.
45. Jackson AL, Loeb LA (2001) The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 477: 7-21. (Pubitemid 32480184)
46. Zhong Y, Kinio A, Saleh M (2013) Functions of NOD-Like Receptors in Human Diseases. Front Immunol 4: 333.
47. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606. (Pubitemid 32531409)
48. Frutuoso MS, Hori JI, Pereira MS, Junior DS, Sonego F, et al. (2010) The pattern recognition receptors Nod1 and Nod2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila. Microbes Infect 12: 819-827.